Remeron is the antidepressant nobody picks first and a lot of guys end up grateful for. The generic name is mirtazapine, it’s been around since the mid-90s, and it does something genuinely weird at the receptor level that makes it one of the more useful tools in the cabinet once you know what it’s for… which, fair warning, almost nobody does the first time they meet it.
Remeron is the antidepressant nobody picks first and a lot of guys end up grateful for.
Most antidepressants work by blocking reuptake. SSRIs (selective serotonin reuptake inhibitors, the Zoloft/Lexapro/Prozac class, the ones that hog all the brochure space) block serotonin reuptake. SNRIs (serotonin and norepinephrine reuptake inhibitors, Effexor and Cymbalta) block both. Mirtazapine doesn’t really do reuptake at all. It blocks the alpha-2 autoreceptor (which is basically the brake pedal on norepinephrine and serotonin release), it blocks the 5-HT2 and 5-HT3 serotonin receptors, and it’s a strong H1 antihistamine, which is the same receptor Benadryl hammers. In English: it lets your brain release more of the good stuff, it dodges the receptors that cause the SSRI nausea and the SSRI dead-libido problem, and it slams the histamine receptor hard enough to put you to sleep and make you hungry.
That last part is the whole story in the clinic. Sleep and appetite. Two side effects that are wreckers for one kind of patient and basically a small miracle for the next one.
The paradoxical dose curve nobody warns residents about
Mirtazapine has a dose curve that confuses everyone the first time they meet it… it’s more sedating at 7.5mg than it is at 30mg. Which sounds backwards and is the kind of thing residents come back to me about thinking they misread something.
The mechanism: at low doses, the antihistamine part dominates and you basically swallowed a Benadryl with extra steps. As the dose climbs, the noradrenergic activity from blocking those alpha-2 autoreceptors ramps up and starts pushing back against the histamine sedation, so a patient on 7.5mg may be face-planting into bed at 9pm and a patient on 45mg may report normal energy during the day. Same drug. Opposite experience. Which is the kind of thing that delights the residents and confuses the patients.
What I tell patients: if we’re using Remeron for sleep, we stay low, 7.5 or 15mg at bedtime. If we’re actually using it as a real antidepressant, we have to get up to 30 or 45mg, and yes, the two weeks at 15mg on the way up are going to feel rough because you’ll be running around half-tranquilized… push through, by week three at 30mg most people are functioning normally during the day. The instinct of every prescriber, mine included, is to titrate slow. With Remeron, slow titration is sometimes the wrong move. If somebody’s stuck at 15mg and miserably out of it, the answer is often to go up, not to give up. Which is one of those things you only believe once you’ve watched it happen.
Sleep, appetite, and the older patient nobody else can help
The classic Remeron candidate is the older guy who’s lost a chunk of weight he didn’t have to lose, isn’t sleeping, and won’t eat. Maybe his wife died eight months ago, maybe he’s been chemo’d through a cancer regimen, maybe both. SSRIs in this population take eight weeks to do anything and often make appetite worse on the way up, which is exactly the wrong direction. Trazodone for sleep helps the insomnia but does nothing for mood or weight. Seroquel works for sleep and appetite but you’re now committing a frail older guy to an antipsychotic with metabolic risk and movement-disorder risk for the rest of his life, which is the kind of trade nobody actually wants to make if there’s a better option on the menu.
Remeron at 15mg at bedtime hits three problems with one pill… sleep inside a few days, appetite inside a week or two, and the actual antidepressant effect coming up underneath all of it by week four to six. For depression in older guys with weight loss, it’s often the single best choice on the menu, and it’s the kind of thing that doesn’t get picked because everyone reflexively starts with sertraline.
Picture a guy whose internist already tried Lexapro and watched him get nauseous and quit, then tried Wellbutrin and watched him get more anxious and sleep worse, and now the family is talking about a feeding tube. Start Remeron 7.5mg at bedtime, and inside two weeks he’s eating breakfast again, which he hasn’t done since the funeral. By week six he’s put on nine pounds and his affect is visibly different to anyone who knew him before. The feeding tube conversation just quietly stops. That’s the version of the story that comes up over and over, and the PCP almost never thinks of Remeron first because Remeron isn’t on anyone’s mental top-three list for depression, which is a shame.
Same story plays out in oncology. Patients on chemo with treatment-related weight loss, nausea, insomnia from steroids, and a depressive overlay sitting on top of all of it. Onc docs love Remeron because the 5-HT3 antagonism (same receptor Zofran hits, the anti-nausea med) also takes care of the nausea, the antihistamine effect handles the sleep, and the weight gain on this drug is a feature, not a bug. I’ve had oncologists call me to start a patient on it specifically because they wanted the weight gain. Which… if we’re being honest, is not a sentence you get to say in clinical medicine very often.
For depression in older guys with weight loss, it’s often the single best choice on the menu, and it’s the kind of thing that doesn’t get picked because everyone reflexively starts with sertraline.
The weight gain is real and it matters who you give it to
Now flip the patient. Mild-to-moderate depression, healthy adult, generally functioning, weight has been a sore spot for a long time, BMI already a few ticks above where they’d like it. Do not give this person Remeron. The weight gain is real, it’s reliable, and on average people put on 5 to 15 pounds in the first six months. Some gain more. There’s no way to dose around it. There’s no behavioral move that reliably blocks it. The drug increases appetite at the receptor level, you eat more, you gain weight, and willpower doesn’t beat that signal for most people.
Patients describe it as being hungry in a way they weren’t before. Standing in front of the open fridge at midnight not really knowing why they’re there. That’s the histamine-driven appetite signal. It’s pharmacological. It’s strong. The patient who’d be devastated to put on twelve pounds shouldn’t be the patient we put on this drug, full stop.
So Remeron is a great drug for the right person and a flat-out wrong call for the wrong one. Who fits: somebody who’s underweight, isn’t sleeping, is older or medically ill, or somebody for whom SSRI sexual side effects have been a dealbreaker (Remeron has almost none of those, which is a real selling point most patients never hear). Who doesn’t fit: a healthy guy with mild depression and a body he’s already self-conscious about. Weight gain isn’t a side effect you can negotiate around. If it’s going to land badly, pick a different drug, because there are like fifteen of them.
When Remeron beats trazodone or Seroquel for sleep
People ask all the time why I’d reach for Remeron instead of trazodone or low-dose Seroquel when the main issue is sleep. Quick rundown.
If mood matters too
Trazodone at 50-100mg is a sleep drug, full stop, not an antidepressant at that dose. Remeron at 7.5-15mg gives you sleep plus a real antidepressant building underneath. Two birds, same pill.
If you want to avoid antipsychotics
Seroquel at 25-50mg works for sleep but you’ve just started someone on an antipsychotic. Metabolic risk, movement disorder risk, harder to come off. Remeron is cleaner if it fits the patient.
Trazodone is still the right answer for plenty of guys. Younger person, no weight issues you’re trying to dodge, just bad sleep, not really depressed… fine, trazodone 50mg, done. But if there’s a mood piece, or weight loss, or SSRIs have failed because the bedroom stopped working, Remeron beats trazodone almost every time. The reason most prescribers don’t think of it first is just habit, which is sort of par for the course in psychiatry, the medications that quietly do useful work don’t get the conference-circuit attention because nobody’s selling them anymore.
California rocket fuel and the refractory case
The other place Remeron shines is in combination. Stephen Stahl coined the term “California rocket fuel” for the combo of venlafaxine (Effexor, the SNRI) plus mirtazapine, and it’s a legitimately effective regimen for treatment-resistant depression (the technical term for depression that hasn’t responded to two reasonable trials of other antidepressants, which sounds like a small slice but is actually about a third of the patients who show up with depression).
The pharmacology actually makes sense if you stare at it for a minute: Effexor boosts serotonin and norepinephrine via reuptake blockade, Remeron boosts both via a completely different mechanism (the alpha-2 and 5-HT2/3 stuff), and the side effects partially cancel out. Effexor causes nausea, Remeron blocks the receptor that drives it. Effexor causes insomnia, Remeron sedates. Effexor causes sexual dysfunction, Remeron doesn’t add to it. None of this is magic, it’s just two drugs that happen to chemically complement each other, which doesn’t happen as often as you’d expect.
The data on the combo is more modest than the nickname suggests, but in practice, for somebody who’s failed two or three SSRIs and an SNRI alone, adding 15-30mg of Remeron at bedtime to ongoing Effexor produces real responses in patients I’d otherwise be sending to TMS (transcranial magnetic stimulation, the magnet-pulses-on-the-prefrontal-cortex outpatient treatment that runs six weeks) or ketamine. Nothing magical happening, just reasonable pharmacology, and it should get tried before escalating to the bigger interventions. If your psychiatrist suggests adding Remeron to whatever you’re already on, that’s what they’re doing, and it’s a real strategy that’s been around long enough to be unfashionable.
Where I land on prescribing it, and the patient gets the call
The honest take: if a patient walks in and wants Remeron, the patient gets Remeron, assuming they’re not somebody for whom weight gain is going to wreck them. I’m a provider, not a parent. The most I’ll do is make it a disapproving yes if I’m genuinely worried about the weight piece, which means they walk out with the script and a real conversation about what I’d watch for and why I wasn’t thrilled. I hardly ever say no to a medication a patient has thought about and wants. The appointment isn’t mine, it’s theirs.
My personal view, which is one data point and you can take it or leave it: most people who come in with mild-to-moderate depression don’t actually need a medication, the sleep work and the naming-the-actual-problem work does most of the heavy lifting. But the older guy who’s not sleeping and not eating and is dropping pounds he can’t afford to drop… that’s a different conversation entirely, and Remeron in that slot is one of the genuinely useful tools in the whole cabinet.
The drug isn’t fashionable. The patent ran out two decades ago and a month’s supply costs about what a sandwich costs. But for the right person, an older guy who isn’t sleeping or eating, a cancer patient with nausea and insomnia, somebody who’s been quietly checked out in bed on every SSRI he’s tried, somebody on max-dose Effexor who needs one more push, Remeron does work that nothing else does as cleanly. Which is the entire case for a drug nobody’s selling. Somebody has to drag you to it. Consider this the drag.
Sources
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs. Lancet. 2018;391(10128):1357-1366. PMID 29477251.
- Watanabe N, Omori IM, Nakagawa A, et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011;(12):CD006528. PMID 22161405.
- Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249-264. PMID 11607047.